UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000061886 |
|---|---|
| Receipt number | R000070812 |
| Scientific Title | Investigation of the Anti-Fatigue and Health-Promoting Effects of the Functional Beverage Dispenser. |
| Date of disclosure of the study information | 2026/06/15 |
| Last modified on | 2026/06/12 13:08:09 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Investigation of the Anti-Fatigue and Health-Promoting Effects of the Functional Beverage Dispenser.
Acronym
Investigation of the Anti-Fatigue and Health-Promoting Effects of the Functional Beverage Dispenser.
Scientific Title
Investigation of the Anti-Fatigue and Health-Promoting Effects of the Functional Beverage Dispenser.
Scientific Title:Acronym
Investigation of the Anti-Fatigue and Health-Promoting Effects of the Functional Beverage Dispenser.
Region
| Japan |
Condition
Condition
Healthy Adult
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Investigation of the Anti-Fatigue and Health-Promoting Effects of the Functional Beverage.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Comprehensive Health Status Score of after taking the functional beverage.
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Ingestion of the test beverage.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 65 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1. Healthy adult individuals currently employed near the measurement facility.
2. Individuals who understand the contents of the informed consent explanation and can provide written consent voluntarily.
Key exclusion criteria
1.Individuals with a history of serious diseases related to the brain, nervous system, cardiovascular system, or other severe conditions, or those currently undergoing treatment, including those taking prescribed medication.
2.Individuals with a history of seizures (such as loss of consciousness, coma, or convulsions) due to neurological disorders.
3.Individuals currently suffering from peptic ulcers (such as gastric ulcers).
4.Individuals who have difficulty performing essential evaluation items in this study due to hearing or visual impairments.
5.Individuals who are currently pregnant or breastfeeding.
6.Individuals who cannot consume sugar-free carbonated beverages and cold drinks.
7.Individuals judged as inappropriate for participation by the principal investigator.
Target sample size
70
Research contact person
Name of lead principal investigator
| 1st name | Kyosuke |
| Middle name | |
| Last name | Watanabe |
Organization
Integrated Health Science Co., Ltd.
Division name
Research Division
Zip code
5300011
Address
JAM-OFFICE 5-D, JAM BASE, 5F, GRAND GREEN OSAKA North 6-38 Ofukacho, Kita-ku, Osaka, JAPAN
TEL
080-2466-6100
contact@integhs.jp
Public contact
Name of contact person
| 1st name | Kyosuke |
| Middle name | |
| Last name | Watanabe |
Organization
Integrated Health Science Co., Ltd.
Division name
Research Division
Zip code
5300011
Address
JAM-OFFICE 5-D, JAM BASE, 5F, GRAND GREEN OSAKA North 6-38 Ofukacho, Kita-ku, Osaka, JAPAN
TEL
080-2466-6100
Homepage URL
contact@integhs.jp
Sponsor or person
Institute
Integrated Health Science Co., Ltd.
Institute
Department
Personal name
Funding Source
Organization
Asahi Soft Drinks Co., LTD.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The Ethics Committee of Umekita Digital Health
Address
JAM-OFFICE 5-D, JAM BASE, 5F, GRAND GREEN OSAKA North 6-38 Ofukacho, Kita-ku, Osaka, JAPAN
Tel
080-2466-6100
hrerc@integhs.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 06 | Month | 15 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 05 | Month | 21 | Day |
Date of IRB
| 2026 | Year | 05 | Month | 27 | Day |
Anticipated trial start date
| 2026 | Year | 06 | Month | 15 | Day |
Last follow-up date
| 2026 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 06 | Month | 12 | Day |
Last modified on
| 2026 | Year | 06 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070812
